On August 15, 2024, CMS announced the 2026 maximum fair prices for the first 10 drugs in the Medicare Drug Price Negotiation Program. Price reductions for the Medicare-negotiated drugs span from 38 percent to 79 percent!

With the majority of premium increases falling on the stand-alone Part D plans in mind, CMS is establishing a new Part D premium stabilization program to prevent market disruption and help maintain consistent and lower-cost PDP options for beneficiaries.

Get ready to inform your clients about the Inflation Reduction Act’s new Medicare Prescription Payment Plan program!

What is Medicare Part D creditable coverage and how is it changing? We cover the creditable drug coverage determination changes and if your clients are at increased risk for late enrollment penalties.

The NABIP Medicare certification training for 2025 is now available! Learn if this certification is right for you.

What does the future of Medicare Part D look like? Ritter believes the health history of the stand-alone PDP market and recent legislation may continue to drive the trend toward MAPD plans.

The Inflation Reduction Act of 2022 brings big changes for Medicare Part D, drug costs, and Affordable Care Act subsidies. Familiarize yourself with these upcoming changes now!

Do you know what your Medicare clients likely spend the most money on out of pocket? Do your clients know what out-of-pocket costs they can expect with Medicare? Here are the most common Medicare out-of-pocket expenses.

If you’re an insurance agent who sells Medicare plans, it’s time to consider how you need to adjust to better serve your clients and their changing needs.